BeOne Medicines AG - ROE
ONC
Price:
$329.5
Market Cap:
$43.44B
BeOne Medicines AG, an oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally. The company’s commercial stage products include BRUKINSA, a small molecule inhibitor of Bruton’s Tyrosine Kinase (BTK) for the treatment of various blood cancers; TEVIMBRA, an anti-PD-1 antibody immunotherapy for the treatment of various solid tumor and blood cancers; SYLVANT for the treatment of adult patients with multicentric castleman disease; BAITUOWEI for patients with BC in premenopausal and perimenopausal women, and cancer; and PARTRUVIX for the treatment of various solid tumors. Its clinical stage products com...[Read more]
Industry
Biotechnology
IPO Date
2016-02-03
Stock Exchange
NASDAQ
Ticker
ONC
PE Ratio
[73.71]
ROE
[12.10%]
Current Ratio
[3.64]
Dividend Yield
[0%]
Enterprise Value
[40.65B]
Dividend History
The ROE as of August 2026 (TTM) for BeOne Medicines AG (ONC) is 12.10%
According to BeOne Medicines AG’s latest financial reports and current stock price. The company's current ROE is 12.10%. This represents a change of 308.13% compared to the average of 2.96% of the last 4 quarters.
BeOne Medicines AG (ONC) Historical ROE (quarterly & annually)
How has ONC ROE performed in the past?
The mean historical ROE of BeOne Medicines AG over the last ten years is -33.13%. The current 12.10% ROE has changed -136.52% with respect to the historical average. Over the past ten years (40 quarters), ONC's ROE was at its highest in in the September 2017 quarter at 15.65%. The ROE was at its lowest in in the December 2019 quarter at -39.66%.
Average
-33.13%
Median
-29.35%
Minimum
-96.96%
Maximum
6.77%
BeOne Medicines AG (ONC) ROE by Quarter and Year
Discovering the peaks and valleys of BeOne Medicines AG ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 182.36%
Maximum Annual ROE = 6.77%
Minimum Annual Increase = -160.20%
Minimum Annual ROE = -96.96%
| Year | ROE | Change |
|---|---|---|
| 2025 | 6.77% | -134.98% |
| 2024 | -19.35% | -22.37% |
| 2023 | -24.93% | -45.47% |
| 2022 | -45.71% | 95.77% |
| 2021 | -23.35% | -44.40% |
| 2020 | -42.00% | -56.69% |
| 2019 | -96.96% | 152.37% |
| 2018 | -38.42% | 182.36% |
| 2017 | -13.61% | -59.72% |
| 2016 | -33.78% | -160.20% |
BeOne Medicines AG (ONC) Average ROE
How has ONC ROE performed in the past?
The current ROE of BeOne Medicines AG (ONC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-12.50%
5-year avg
-21.31%
10-year avg
-33.13%
BeOne Medicines AG (ONC) ROE vs. Peers
How is ONC’s ROE compared to its peers?
BeOne Medicines AG’s ROE is less than Humana Inc. (6.91%), greater than Insmed Incorporated (-130.11%), less than GE HealthCare Technologies Inc. (15.16%), less than ResMed Inc. (24.41%), less than IQVIA Holdings Inc. (21.95%), less than Alcon Inc. (3.69%), greater than Mettler-Toledo International Inc. (-1199.91%), greater than Natera, Inc. (-15.13%), less than Koninklijke Philips N.V. (10.05%), less than Agilent Technologies, Inc. (20.84%),
| Company | ROE | Market cap |
|---|---|---|
| 6.91% | $43.39B | |
| -130.11% | $21.80B | |
| 15.16% | $31.81B | |
| 24.41% | $32.24B | |
| 21.95% | $38.54B | |
| 3.69% | $34.55B | |
| -1199.91% | $29.00B | |
| -15.13% | $39.62B | |
| 10.05% | $25.87B | |
| 20.84% | $39.24B |
Build a custom stock screener for BeOne Medicines AG (ONC) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BeOne Medicines AG using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
BeOne Medicines AG (ONC) and other stocks custom spreadsheet templates
The easiest way to analyze a company like BeOne Medicines AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is BeOne Medicines AG's ROE?
How is the ROE calculated for BeOne Medicines AG (ONC)?
What is the highest ROE for BeOne Medicines AG (ONC)?
What is the 3-year average ROE for BeOne Medicines AG (ONC)?
What is the 5-year average ROE for BeOne Medicines AG (ONC)?
How does the current ROE for BeOne Medicines AG (ONC) compare to its historical average?